Quantabio is committed to supporting molecular testing for public health applications with our ToughMix PCR, qPCR and RT-qPCR reagents as well as NGS solutions. Since 2013, Quantabio products have been cited in testing protocols for viruses such as H7N9 Avian Influenza, Polio and COVID-19 and bacteria such as Legionella spp., Mycoplasma pneumoniae and Shiga toxin producing E. coli. These protocols are continually expanded to include new pathogens, or improve previous assays.

•  Viral Respiratory Assay 
•  Fungal/Bacterial/Viral ID Assays 
•  NBS Assays for inherited disease 

All Quantabio products and reagents are intended for molecular biology applications. The products are not intended for the diagnosis, prevention or treatment of a disease.